Y Xie, B Bowe, Z Al-Aly - The BMJ, 2023 - ncbi.nlm.nih.gov
Objective To emulate a randomized target trial to estimate the association between the antiviral drug molnupiravir and hospital admission or death in adults with SARS-CoV-2 …
Y Xie, B Bowe, Z Al-Aly - BMJ (Clinical Research ed.), 2023 - europepmc.org
Objective To emulate a randomized target trial to estimate the association between the antiviral drug molnupiravir and hospital admission or death in adults with SARS-CoV-2 …
Objective To emulate a randomized target trial to estimate the association between the antiviral drug molnupiravir and hospital admission or death in adults with SARS-CoV-2 …
Y Xie, B Bowe, Z Al-Aly - BMJ: British Medical Journal (Online), 2023 - search.proquest.com
Objective To emulate a randomized target trial to estimate the association between the antiviral drug molnupiravir and hospital admission or death in adults with SARS-CoV-2 …
Y Xie, B Bowe, Z Al-Aly - bmj, 2023 - scienceopen.com
Objective To emulate a randomized target trial to estimate the association between the antiviral drug molnupiravir and hospital admission or death in adults with SARS-CoV-2 …
Y Xie, B Bowe, Z Al-Aly - 2023 - digitalcommons.wustl.edu
Objective To emulate a randomized target trial to estimate the association between the antiviral drug molnupiravir and hospital admission or death in adults with SARS-CoV-2 …
Y Xie, B Bowe, Z Al-Aly - BMJ (Clinical research ed.), 2023 - pubmed.ncbi.nlm.nih.gov
Objective To emulate a randomized target trial to estimate the association between the antiviral drug molnupiravir and hospital admission or death in adults with SARS-CoV-2 …
Y Xie, B Bowe, Z Al-Aly - bmj, 2023 - colmedicosantafe2.org.ar
Objective To emulate a randomized target trial to estimate the association between the antiviral drug molnupiravir and hospital admission or death in adults with SARS-CoV-2 …
Objective To emulate a randomized target trial to estimate the association between the antiviral drug molnupiravir and hospital admission or death in adults with SARS-CoV-2 …